10x Capital Venture Acquisition Corp Iii Asset Turnover Ratio (VCXBU), as of third quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
10x Capital Venture Acquisition Corp Iii  (NYSE: VCXBU)
 

10x Capital Venture Acquisition Iii Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Sep 30 2023, 10x Capital Venture Acquisition Corp Iii has not recorded any assets.
Visit 10x Capital Venture Acquisition Corp Iii Balance sheet

Within sector 10x Capital Venture Acquisition Corp Iii achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Third Quarter 2023 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VCXBU Asset Turnover Ratio (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Asset Change -85.69 % -85.58 % -85.25 % 54264.67 % -
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) - - 0.02 - -
VCXBU's Total Ranking # # # # #
Seq. Asset Change -0.55 % -2.23 % -85.38 % 0.64 % 0.23 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




VCXBU Company Profile • Back to VCXBU Efficiency Comparisons • Compare VCXBU Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Assets at quarter ending Sep 30 2023
Mirum Pharmaceuticals Inc   0.33 $ 144.726  Millions$ 445.167  Millions
Amgen Inc   0.32 $ 26,833.000  Millions$ 83,661.000  Millions
Guardant Health Inc   0.32 $ 535.785  Millions$ 1,689.716  Millions
Regen Biopharma Inc   0.32 $ 0.127  Millions$ 0.401  Millions
Viatris Inc   0.31 $ 15,465.600  Millions$ 49,187.550  Millions
Apellis Pharmaceuticals Inc   0.31 $ 272.877  Millions$ 868.220  Millions
Yubo International Biotech Limited  0.31 $ 0.653  Millions$ 2.082  Millions
Aurinia Pharmaceuticals Inc   0.31 $ 158.853  Millions$ 506.634  Millions
Sotera Health Company  0.31 $ 989.752  Millions$ 3,160.830  Millions
Glaukos Corp  0.31 $ 303.063  Millions$ 970.087  Millions
Avid Bioservices Inc   0.31 $ 139.466  Millions$ 450.122  Millions
The Cooper Companies Inc   0.31 $ 3,592.900  Millions$ 11,597.000  Millions
Arrowhead Pharmaceuticals Inc   0.31 $ 240.735  Millions$ 786.164  Millions
Immunome Inc   0.30 $ 15.741  Millions$ 51.689  Millions
Deciphera Pharmaceuticals Inc   0.30 $ 151.407  Millions$ 502.628  Millions
Capricor Therapeutics inc   0.30 $ 14.050  Millions$ 46.780  Millions
Ultragenyx Pharmaceutical Inc   0.30 $ 410.205  Millions$ 1,369.575  Millions
Medinotec Inc   0.30 $ 1.434  Millions$ 4.802  Millions
Veracyte Inc   0.30 $ 343.149  Millions$ 1,149.900  Millions
T2 Biosystems Inc   0.30 $ 10.997  Millions$ 36.868  Millions
23andme Holding Co  0.30 $ 269.726  Millions$ 909.920  Millions
Acorda Therapeutics Inc   0.30 $ 111.118  Millions$ 375.385  Millions
Kyntra Bio Inc   0.29 $ 154.980  Millions$ 531.046  Millions
Cvrx inc   0.29 $ 33.958  Millions$ 117.251  Millions
Twist Bioscience Corporation  0.29 $ 245.109  Millions$ 850.509  Millions
Standard Biotools Inc   0.29 $ 104.896  Millions$ 364.269  Millions
Elanco Animal Health Incorporated  0.28 $ 4,363.000  Millions$ 15,350.000  Millions
Telesis Bio Inc   0.28 $ 27.670  Millions$ 97.520  Millions
Molecular Templates Inc   0.28 $ 18.064  Millions$ 63.907  Millions
Palatin Technologies Inc   0.28 $ 6.090  Millions$ 21.693  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.